Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;3(2):134-41.
doi: 10.3978/j.issn.2225-319X.2014.03.08.

Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer

Christopher Cao  1 , Sunil Gupta  1 , David Chandrakumar  1 , David H Tian  1 , Deborah Black  1 , Tristan D Yan  1
Affiliations
Review

Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer

Christopher Cao et al. Ann Cardiothorac Surg. 2014 Mar.

Abstract

Background: Surgical resection is the preferred treatment modality for eligible candidates with non-small cell lung cancer (NSCLC). However, the selection of sublobar resection versus lobectomy for early-stage NSCLC remains controversial. Previous meta-analyses comparing these two procedures presented data without considering the significant differences in the patient selection processes in individual studies. The present study aimed to compare the overall survival (OS) and disease-free survival (DFS) outcomes of patients who underwent sublobar resections who were also eligible for lobectomy procedures with those who underwent lobectomy.

Methods: An electronic search was conducted using five online databases from their dates of inception to December 2013. Studies were selected according to predefined inclusion criteria and meta-analyzed using hazard ratio (HR) calculations.

Results: Twelve studies met the selection criteria, including 1,078 patients who underwent sublobar resections and 1,667 patients who underwent lobectomies. From the available data, there was no significant differences in OS [HR 0.91; 95% confidence interval (CI) 0.64-1.29] or DFS (HR 0.82; 95% CI 0.60-1.12) between the two treatment arms. In addition, no significant OS difference was detected for patients who underwent segmentectomies compared to lobectomies (HR 1.04; 95% CI 0.66-1.63, P=0.86).

Conclusions: Using the available data in the current literature, patients who underwent sublobar resection for small, peripheral NSCLC after intentional selection rather than ineligibility for greater resections achieved similar long-term survival outcomes as those who underwent lobectomies. However, patients included for the present meta-analysis were a highly selected cohort and these results should be interpreted with caution. The importance of the patient selection process in individual studies must be acknowledged to avoid conflicting outcomes in future meta-analyses.

Keywords: Sublobar resection; meta-analysis; non-small cell lung cancer (NSCLC); segmentectomy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of search strategy performed to identify relevant comparative studies on sublobar resections vs. lobectomies for early-stage NSCLC. NSCLC, non-small cell lung cancer.
Figure 2
Figure 2
Overall survival: sublobar vs. lobectomy. CI, confidence interval.
Figure 3
Figure 3
Disease-free survival: sublobar vs. lobectomy. CI, confidence interval.
Figure 4
Figure 4
Overall survival: segmentectomy vs. lobectomy. CI, confidence interval.
See this image and copyright information in PMC

References

    1. Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e278S-313S. - PubMed
    1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22; discussion 622-3 - PubMed
    1. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16. - PMC - PubMed
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34 - PubMed
    1. Read RC, Yoder G, Schaeffer RC. Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. Ann Thorac Surg 1990;49:391-8; discussion 399-400 - PubMed